Pamela Abdayem Selected Research

tusamitamab ravtansine

1/2022

Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pamela Abdayem Research Topics

Disease

3	Neoplasms (Cancer) 11/2022 - 02/2015
2	Lung Neoplasms (Lung Cancer) 05/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2014
1	Tuberculosis (Tuberculoses) 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Fatigue 04/2021
1	Sepsis (Septicemia) 04/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021
1	Frailty 04/2021

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 05/2022 - 06/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2022
1	Mitogen-Activated Protein KinasesIBA 11/2022
1	Programmed Cell Death 1 ReceptorIBA 05/2022
1	pembrolizumabIBA 05/2022
1	B7-H1 AntigenIBA 05/2022
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	lorvotuzumab mertansineIBA 01/2022
1	rovalpituzumab tesirineIBA 01/2022
1	tusamitamab ravtansineIBA 01/2022
1	sacituzumab govitecanIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	telisotuzumab vedotinIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 04/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021
1	Rituximab (Mabthera)FDA Link 04/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2021
1	MTOR InhibitorsIBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2014
1	Gemcitabine FDA Link 01/2014

Therapy/Procedure

1	Immunotherapy 05/2022
1	Drug Therapy (Chemotherapy) 04/2021
1	Therapeutics 02/2015